These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26677977)

  • 1. Multikinase Inhibitors Induce Cutaneous Toxicity through OAT6-Mediated Uptake and MAP3K7-Driven Cell Death.
    Zimmerman EI; Gibson AA; Hu S; Vasilyeva A; Orwick SJ; Du G; Mascara GP; Ong SS; Chen T; Vogel P; Inaba H; Maitland ML; Sparreboom A; Baker SD
    Cancer Res; 2016 Jan; 76(1):117-26. PubMed ID: 26677977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E
    Shichiri H; Yamamoto K; Tokura M; Ishida T; Uda A; Bito T; Nishigori C; Nakagawa T; Hirano T; Yano I; Hirai M
    Biochem Biophys Res Commun; 2017 Apr; 485(2):227-233. PubMed ID: 28237700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrimination of hand-foot skin reaction caused by tyrosine kinase inhibitors based on direct keratinocyte toxicity and vascular endothelial growth factor receptor-2 inhibition.
    Hasan Alshammari A; Masuo Y; Fujita KI; Shimada K; Iida N; Wakayama T; Kato Y
    Biochem Pharmacol; 2022 Mar; 197():114914. PubMed ID: 35041812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib.
    Lee WJ; Lee JL; Chang SE; Lee MW; Kang YK; Choi JH; Moon KC; Koh JK
    Br J Dermatol; 2009 Nov; 161(5):1045-51. PubMed ID: 19558553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Ascorbyl-2-phosphate Magnesium on Human Keratinocyte Toxicity and Pathological Changes by Sorafenib.
    Yamamoto K; Shichiri H; Ishida T; Kaku K; Nishioka T; Kume M; Makimoto H; Nakagawa T; Hirano T; Bito T; Nishigori C; Yano I; Hirai M
    Biol Pharm Bull; 2017; 40(9):1530-1536. PubMed ID: 28867735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. s-HBEGF/SIRT1 circuit-dictated crosstalk between vascular endothelial cells and keratinocytes mediates sorafenib-induced hand-foot skin reaction that can be reversed by nicotinamide.
    Luo P; Yan H; Chen X; Zhang Y; Zhao Z; Cao J; Zhu Y; Du J; Xu Z; Zhang X; Zeng S; Yang B; Ma S; He Q
    Cell Res; 2020 Sep; 30(9):779-793. PubMed ID: 32296111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of toxicity of sorafenib and sunitinib for human keratinocytes with inhibition of signal transduction and activator of transcription 3 (STAT3).
    Yamamoto K; Mizumoto A; Nishimura K; Uda A; Mukai A; Yamashita K; Kume M; Makimoto H; Bito T; Nishigori C; Nakagawa T; Hirano T; Hirai M
    PLoS One; 2014; 9(7):e102110. PubMed ID: 25013907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of hand-foot skin reaction with sorafenib: a systematic review and meta-analysis.
    Chu D; Lacouture ME; Fillos T; Wu S
    Acta Oncol; 2008; 47(2):176-86. PubMed ID: 18210295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib.
    Louandre C; Ezzoukhry Z; Godin C; Barbare JC; Mazière JC; Chauffert B; Galmiche A
    Int J Cancer; 2013 Oct; 133(7):1732-42. PubMed ID: 23505071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinome and Transcriptome Profiling Reveal Broad and Distinct Activities of Erlotinib, Sunitinib, and Sorafenib in the Mouse Heart and Suggest Cardiotoxicity From Combined Signal Transducer and Activator of Transcription and Epidermal Growth Factor Receptor Inhibition.
    Stuhlmiller TJ; Zawistowski JS; Chen X; Sciaky N; Angus SP; Hicks ST; Parry TL; Huang W; Beak JY; Willis MS; Johnson GL; Jensen BC
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29051215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The kinase inhibitor sorafenib induces cell death through a process involving induction of endoplasmic reticulum stress.
    Rahmani M; Davis EM; Crabtree TR; Habibi JR; Nguyen TK; Dent P; Grant S
    Mol Cell Biol; 2007 Aug; 27(15):5499-513. PubMed ID: 17548474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Search for evidence-based approaches for the prevention and palliation of hand-foot skin reaction (HFSR) caused by the multikinase inhibitors (MKIs).
    Anderson R; Jatoi A; Robert C; Wood LS; Keating KN; Lacouture ME
    Oncologist; 2009 Mar; 14(3):291-302. PubMed ID: 19276294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of tyrosine kinase inhibitor-induced hand-foot skin reaction: viewpoints from the medical oncologist, dermatologist, and oncology nurse.
    Manchen E; Robert C; Porta C
    J Support Oncol; 2011; 9(1):13-23. PubMed ID: 21465734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of hand-foot skin reaction associated with the multikinase inhibitors sorafenib and sunitinib on health-related quality of life.
    Nardone B; Hensley JR; Kulik L; West DP; Mulcahy M; Rademaker A; Lacouture ME
    J Drugs Dermatol; 2012 Nov; 11(11):e61-5. PubMed ID: 23135095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving strategies for the management of hand-foot skin reaction associated with the multitargeted kinase inhibitors sorafenib and sunitinib.
    Lacouture ME; Wu S; Robert C; Atkins MB; Kong HH; Guitart J; Garbe C; Hauschild A; Puzanov I; Alexandrescu DT; Anderson RT; Wood L; Dutcher JP
    Oncologist; 2008 Sep; 13(9):1001-11. PubMed ID: 18779536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of Probenecid on the Pharmacokinetics and Pharmacodynamics of Sorafenib.
    Hussaarts KGAM; van Doorn L; Eechoute K; Damman J; Fu Q; van Doorn N; Eisenmann ED; Gibson AA; Oomen-de Hoop E; de Bruijn P; Baker SD; Koolen SLW; van Gelder T; van Leeuwen RWF; Mathijssen RHJ; Sparreboom A; Bins S
    Pharmaceutics; 2020 Aug; 12(9):. PubMed ID: 32825359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide in multikinase inhibitor-induced hand-foot skin reaction.
    Chen L; Wu Z; Yang L; Chen Y; Wang W; Cheng L; Li C; Lv D; Xia L; Chen J; Tang L; Zhang LI; Zhang S; Luo J
    Transl Res; 2022 Jul; 245():82-98. PubMed ID: 35189405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial of the prophylactic effect of urea-based cream on sorafenib-associated hand-foot skin reactions in patients with advanced hepatocellular carcinoma.
    Ren Z; Zhu K; Kang H; Lu M; Qu Z; Lu L; Song T; Zhou W; Wang H; Yang W; Wang X; Yang Y; Shi L; Bai Y; Guo X; Ye SL
    J Clin Oncol; 2015 Mar; 33(8):894-900. PubMed ID: 25667293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status.
    Broecker-Preuss M; Müller S; Britten M; Worm K; Schmid KW; Mann K; Fuhrer D
    BMC Cancer; 2015 Mar; 15():184. PubMed ID: 25879531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multikinase inhibitor sorafenib induces skin toxicities in tumor-bearing mice.
    Tian A; Lu H; Zhang J; Fu S; Jiang Z; Lam W; Guan F; Chen L; Feng L; Cheng Y
    Cancer Chemother Pharmacol; 2018 Jun; 81(6):1025-1033. PubMed ID: 29633006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.